Mammoth Biosciences vs Tolemy Bio
Mammoth Biosciences vs Tolemy Bio, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Mammoth Biosciences is on 63/100 and Tolemy Bio on 46/100.
Where each one leads
Mammoth Biosciences
- our overall score: 63/100 against 46/100
- agent readiness: 35/100 against 22/100
- headcount: 165 against 4
- funding raised: $460M against $1.4M
- LinkedIn following: 57,986 against 1,736
Tolemy Bio
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Mammoth Biosciences | Tolemy Bio |
|---|---|---|
| What it is | Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics. | AI-enabled technology for cell biology research and biopharma development. |
| Category | Biotechnology, Drug Discovery, Genomics, CRISPR Technology | Biotechnology, Artificial Intelligence, Drug Discovery, Life Sciences |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2017 | 2022 |
| Headquarters | Brisbane, United States | Cambridge, United Kingdom |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Mammoth Biosciences | Tolemy Bio |
|---|---|---|
| Employees | 165 | 4 |
| Headcount growthLast 12 months | +5.8% | Not published |
| Total funding | $460M | $1.4M |
| Latest round | Funding Round | Pre-Seed |
| Valuation | $1.1B | Not published |
| LinkedIn followers | 57,986 | 1,736 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Mammoth Biosciences | Tolemy Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 63/100 | 46/100 |
| Traction | 60/100 | 38/100 |
| Team | 70/100 | 70/100 |
| Community | Not published | 15/100 |
| Search visibility | 35/100 | 39/100 |
| Quality | 68/100 | 48/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (35/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 53/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Mammoth Biosciences | Tolemy Bio |
|---|---|---|
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Not detected |
| Support stack | HubSpot | Not detected |
Mammoth Biosciences vs Tolemy Bio: common questions
Which is better, Mammoth Biosciences or Tolemy Bio?
On our 0-100 score Mammoth Biosciences rates higher (63/100 against 46/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Mammoth Biosciences and Tolemy Bio compare on the numbers?
Mammoth Biosciences leads on our overall score (63/100 against 46/100), agent readiness (35/100 against 22/100), headcount (165 against 4), funding raised ($460M against $1.4M), LinkedIn following (57,986 against 1,736).
Read the full Mammoth Biosciences review and pricing or the Tolemy Bio review and pricing. You can also browse other Mammoth Biosciences alternatives we track.